This report was first published by Endpoints News. To see the original version, click here
The FDA is getting closer to announcing a director of the Center for Biologics Evaluation and Research, sources told Endpoints News, following the controversial tenure of outgoing leader Vinay Prasad.
A leading candidate for the post is Houman Hemmati, people who spoke on condition of anonymity told Endpoints. Hemmati is a longtime biotech executive and ophthalmologist who has served in more than a dozen industry roles, posts heavily on social media and has raised questions about the Covid-19 vaccine.
您已阅读17%（595字），剩余83%（2944字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。